Pancreas removal plus islet transplant: a new option for benign tumors?
NCT ID NCT05453851
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a surgery that removes the entire pancreas and then transplants the patient's own insulin-making cells into the liver. The goal is to treat chronic pancreatitis and benign tumors while reducing the risk of diabetes. The study includes 12 adults with adequate islet function and will check for safety and whether the procedure prevents cancer spread.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PANCREATIC NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood and gut clues may flag pancreatic cancer risk early
- Can a lung drug tame the pain of chronic pancreatitis?
- Can a Decades-Old drug reverse pancreatic scarring?
- Can we predict who will develop pancreatic cancer from chronic pancreatitis?
- Brain scans reveal hidden pain pathways in chronic pancreatitis
- New device aims to make pancreatic and bile duct procedures safer